Cardinal Health Clears $262 for a Fresh 52-Week High

Cardinal Health touched $262.01 on November 4, surpassing its previous 52-week peak set on October 20. That prior high held for less than three weeks before the stock pushed through it, a sign of persistent buying pressure.

A long base in the $193 to $210 range gave way to a steady climb through the summer and fall. That pattern tends to draw attention from momentum-oriented investors.

For a drug distributor, reaching successive all-time highs in a compressed window signals that investors are rewarding the business model. Cardinal Health sits at the center of pharmaceutical supply chains, a position that generates steady, recurring revenue regardless of broader economic cycles.

The immediate question for investors is whether the stock can hold above the prior high or whether the breakout stalls and pulls back to test that level as support. With the 52-week high now reset at $262.01, that October 20 peak becomes the first floor worth monitoring on any near-term dip.